In view of great variability in plasma glucose levels despite adherence to treatment, C-peptide levels showing insulin secretion (which is not compatible with T1DM), absence of GAD antibodies, and, most importantly, a strong family history of diabetes in the mother and maternal grandmother, the diagnosis of MODY was suspected and confirmed as HNF1A MODY by molecular testing. This evidence concerns the gene INS and diabetes mellitus.